You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitor (ICI) therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))

Recruiting
  • Cancer
  • +2 more
  • Fecal Microbiota Transplantation (FMT)
  • Zurich, Switzerland
    University of Zurich, University Hospital Zurich
Jun 14, 2022

Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • increasing total fiber intake
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Apr 6, 2023

Solid Tumor, Adult Trial in United States (IMSA101, Immune checkpoint inhibitor (ICI), Immuno-oncology (IO) therapy)

Recruiting
  • Solid Tumor, Adult
  • Scottsdale, Arizona
  • +5 more
Apr 14, 2022

Intestinal Biomarker Analysis After ECP for ICI Colitis

Recruiting
  • Colitis
  • Immune Checkpoint Inhibitor-Related Colitis
  • Intestinal tissue analysis
  • Freiburg, Baden Württemberg, Germany
    Freiburg University Medical Center
Oct 5, 2023

Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Recruiting
  • Graft Rejection
  • +3 more
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
Jun 21, 2023

Solid Tumor, Adult Trial (IMSA101, Immune Checkpoint Inhibitor)

Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
Sep 6, 2023

Cutaneous Toxicity From ICI Therapy Trial in Baltimore (Immune checkpoint inhibitor (ICI))

Completed
  • Cutaneous Toxicity From ICI Therapy
  • Immune checkpoint inhibitor (ICI)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Care Center
May 19, 2021

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Intensity Modulated Radiation Therapy
  • +3 more
  • (no location specified)
Jul 11, 2023

Oligometastatic Disease Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligometastatic Disease
  • (no location specified)
May 5, 2023

Oligoprogressive Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligoprogressive
  • (no location specified)
May 5, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

Recruiting
  • Immune-Mediated Colitis
  • Tofacitinib 10 mg
  • Montreal, Quebec, Canada
    Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
May 11, 2022

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023

Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

Not yet recruiting
  • Stage IV NSCLC
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Sep 28, 2023

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Myocarditis Acute, Cancer Trial in Boston (Abatacept plus, Placebo)

Recruiting
  • Myocarditis Acute
  • Cancer
  • Abatacept plus
  • Placebo
  • Los Angeles, California
  • +16 more
Feb 1, 2023

Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

Not yet recruiting
  • Immune-related Colitis
  • Colitis
  • Minneapolis, Minnesota
    University of Minnesota
Feb 4, 2023

Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

Not yet recruiting
  • Breast Cancer
  • Contrast Enhanced Ultrasound
  • Hershey, Pennsylvania
    Penn State Health College of Medicine
Jul 19, 2023

EXploring Immune-related Adverse Events of Immune checkpoinT

Active, not recruiting
  • Cancer
  • +2 more
  • Immune checkpoint inhibitor
  • Paris, France
  • +1 more
Jul 5, 2023

Immune Checkpoint Inhibitor Monotherapy or Combined With

Not yet recruiting
  • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Cancer Trial in Rochester (PET/CT)

    Completed
    • Cancer
    • PET/CT
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 3, 2022

    Determine Pro-Inflammatory Cytokine Kinetics During Immune

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Melanoma
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Jan 30, 2023

      Immune Checkpoint Inhibitor-related Cardiotoxicity

      Not yet recruiting
      • Immune Checkpoint Inhibitors, Cardiotoxicity
      • Cardiac magnetic resonance
      • (no location specified)
      Nov 10, 2023